Chromosomal losses involving the short arm of chromosome 8 are frequent in a variety of tumor types, including breast cancer, suggesting the presence of one or more tumor suppressor genes in this region. Previous linkage analysis and studies of loss of heterozygosity (LOH) have suggested the presence of a putative third breast cancer susceptibility gene around D8S505 at 8p12-p22. We have performed linkage analysis in two German breast cancer families, showing negative lod scores with 17q and 13q markers, using seven adjacent microsatellite markers from 8p12-p22. Incorporating LOH data from tumors of the aected family members a maximum cumulative three-point lod score of 3.30 at Y=0.00 was obtained with D8S137 and D8S131. Our ®ndings considerably strengthen the evidence for a third breast cancer susceptibility locus (BRCA3) mapping to the short arm of human chromosome 8.
Introduction
A family history of breast cancer is a well established risk factor for the disease. On estimate 5% to 10% of all breast and ovarian cancers are attributable to inherited mutations in highly penetrant autosomal dominant susceptibility genes (Claus et al., 1991) . As yet two such genes, BRCA1 and BRCA2, have been identi®ed on chromosomes 17q21 and 13q13, respectively (Miki et al., 1994; Wooster et al., 1995) .
As they appear to account for approximately twothirds of autosomal dominantly inherited breast cancers additional genes predisposing to breast cancer are likely to exist (Stratton and Wooster, 1996; Sobol et al., 1994) . Several candidate regions potentially harbouring such genes have been suggested on the basis of linkage and mutational analyses, including 6q25 around the estrogen receptor (ESR) locus (Zuppan et al., 1991) and 8p12-p22 (Kerangueven et al., 1995; Imbert et al., 1996) . Losses of heterozygosity at proximal 8p have been observed in a range of apparently sporadic epithelial carcinomas, including breast cancer (Devilee et al., 1991; Knowles et al., 1993; Kelemen et al., 1994; Shibagaki et al., 1994; Wasylyshyn et al., 1991; Emi et al., 1992; Cliby et al., 1993; Macoska et al., 1995) , indicative of the presence of at least one tumor suppressor gene. However, statistical evidence for additional breast cancer susceptibility loci has been relatively weak and independent con®rmation has not been reported.
Based on linkage-and LOH data from two German breast cancer families this study points strong evidence for the presence of a third breast cancer susceptibility gene on chromosome 8p.
Results and discussion
Of the 36 German families with a minimum of three con®rmed cases of breast cancer of families collected in the course of a nationwide project (Zimmermann et al., 1993) eight yielded negative lod scores for markers within or closely linked to the BRCA1 and BRCA2 genes. Based on available mapping data for 8p12-p22 we selected the following seven microsatellite markers (in telomer-centromer order) D8S133, D8S136, NEFL, D8S137, D8S131, D8S339, D8S259 to perform focused linkage analyses in this subset. Two of these families, MDC family 59 and, the larger one MDC family 60 ( Figure 1 ) showed a maximum three-point lod score of 0.37 and 2.04 for the markers D8S137 and D8S131 at Y=0.0 with the markers 1 cM apart. The¯anking pairwise lod scores with NEFL (0.38 and 0.69) and D8S339 (0.12 and 70.54 with two informative recombination events at 312 and 415 in MDC family 60) de®ne the [3,3,6]haplotype encompassing NEFL-D8S137-D8S131 as the risk haplotype. Interestingly this haplotype is shared by a patient with a endometrial carcinoma diagnosed at 55 years.
For both pedigrees sucient tumor specimens were available to allow LOH analyses for the seven distal microsatellite markers in the breast cancer carriers.
In MDC family 60 aected tumors 302, 401 and 402 showed loss of the wildtype (LOWT) allele for D8S136, one tumor (401) showed LOWT at NEFL, while two were uninformative and one (402) showed retention. One tumor (302) showed LOWT at D8S137, while the remaining three were uninformative. Three tumors (302, 402, 416) displayed LOWT for D8S131 and two (302, 402) for D8S339, the remaining tumors showing retention for these markers.
These LOH data were incorporated into the likelihood calculations using a recent modi®cation of the MLINK program (Rohde et al., 1995) . Calculating three-point lod scores a maximum of 2.93 was obtained at Y=0.00 centered at D8S137, with D8S131 set 1 cM apart and taken in account the three LOWT at D8S131. Cumulative three-point lod scores for D8S137-D8S131 at Y=0.0 were 2.41 and 3.30, without and with incorporation of the LOH data, respectively.
These ®ndings considerably strengthen earlier suggestions of a third breast cancer susceptibility locus (BRCA3) mapping to a segment on proximal 8p between NEFL and D8S505 encompassing approximately 20 cM (Kerangueven et al., 1995; Imbert et al., 1996) . These data were based mainly on cumulative linkage analyses of eight French families, whose individual lod scores did not signi®cantly exceed 0.5 for NEFL-D8S259 (Kerangueven et al., 1995) .
The recombination events in MDC family 60 reduce the chromosomal region potentially harbouring BRCA3 to approximately 7 cM (Yu et al., 1996) . While previously there were no obvious candidate genes in this region, recently a putative helicase has been identi®ed less than 1 Mb centromeric of D8S339. Four germ line mutations of this gene (WRN) have been detected in a number of patients with Werner's syndrome, a disease characterized by premature aging and an increased incidence of neoplasms including breast cancer. Whether WRN or another yet unknown gene on 8p12-p22 will prove to be the third breast cancer susceptibility gene (BRCA3) remains to be determined.
Materials and methods

Families
The two families (#59 and #60) studied were collected at the Department of tumor genetics of the Max Delbrueck Center for Molecular Medicine, Berlin-Buch, Germany. MDC families 59 and 60 had an average age at diagnosis of breast cancer of 52 and 43.3 years, respectively. Blood samples and tumor specimens were coded and the con®dentiality of the patients was preserved. Blood samples were obtained for the extraction of genomic DNA which was isolated from whole blood by standard procedures.
Microsatellite typing and linkage analysis
Microsatellite typing was done employing standard procedures. To establish the probability that a family was linked to BRCA1 allelotyping was performed using the BRCA1¯anking or intragenic microsatellite markers D17S250, D17S588 and D17S579. Linkage to BRCA2 was assessed using the chromosome 13 markers D13S289, D13S260 and D13S267. Linkage to the chromosome region 8p12-p22 was performed using the seven markers described in the text. The penetrance and gene frequencies are based on the CASH-model (Claus et al., 1991) , the parameters for including LOH (Cottingham et al., 1993) were taken conservative with equal probability 0.3 of LOH for sporadic and linked cases and probability 1.0 (rho=0) that the allele retained in tumor LOH is the disease allele. Linkage calculations were performed using the program MLINK of FASTLINK (Cottingham et al., 1993) and VITESSE (O'Connell and Weeks, 1995) and, for the inclusion of LOH with the modi®ed program LMLINK (Rohde et al., 1995) .
Loss of heterozygosity analysis
Tumor specimens from MDC families 59 and 60 were retrieved from pathology archives, reviewed and microdissected according to morphologic and immunohistologic criteria. DNA was puri®ed from tumorous and adjacent normal tissues using standard procedures and subjected to LOH analyses. PCR conditions and primer sequences for the seven microsatellites covering the 8p12-p22 region were taken from GDB and modi®ed in some cases. LOH was assessed by direct visual comparison of the relative allelic ratios of the normal and tumor sample on the autoradiographs.
